Carlos Gustavo De Moraes, MD, MPH, PhD; Simon W. M. John, PhD; Pete A. Williams, PhD; et al.
free access
has active quiz
JAMA Ophthalmol. 2022;140(1):11-18. doi:10.1001/jamaophthalmol.2021.4576
This phase 2 randomized clinical trial tests the hypothesis that a combination of nicotinamide and pyruvate can improve retinal ganglion cell function in individuals with glaucoma as measured with standard automated perimetry.
Arshad M. Khanani, MD, MA; Marco A. Zarbin, MD, PhD; Mark R. Barakat, MD; et al.
open access
JAMA Ophthalmol. 2022;140(1):20-28. doi:10.1001/jamaophthalmol.2021.4585
This cohort study assesses the real-world incidence of intraocular inflammation, including retinal vasculitis and/or retinal vascular occlusion for patients with neovascular age-related macular degeneration who underwent brolucizumab treatment.
Swathi Kaliki, MD; Carol L. Shields, MD; Nathalie Cassoux, MD, PhD; et al.
free access
JAMA Ophthalmol. 2022;140(1):30-36. doi:10.1001/jamaophthalmol.2021.4732
This survey study evaluates variations in the definition of high-risk histopathologic features for metastasis of retinoblastoma in different ocular oncology practices around the world.
Gerald McGwin Jr, MS, PhD; Paul MacLennan, MPH, PhD; Cynthia Owsley, PhD, MSPH
free access
JAMA Ophthalmol. 2022;140(1):37-42. doi:10.1001/jamaophthalmol.2021.4778
This analysis of disproportionality used adverse event reports to assess the association of pentosan polysulfate sodium exposure and maculopathy.
Juan M. Lavista Ferres, MSC; Thomas Meirick, MD; Whitney Lomazow, MD; et al.
free access
has active quiz
JAMA Ophthalmol. 2022;140(1):43-49. doi:10.1001/jamaophthalmol.2021.4852
This comparative effectiveness study evaluates whether internet search interest and emergency department visits for infectious conjunctivitis were associated with public health interventions adopted during the COVID-19 pandemic.
Patricia Bai, BA; Andrew J. Barkmeier, MD; David O. Hodge, MS; et al.
free access
JAMA Ophthalmol. 2022;140(1):51-57. doi:10.1001/jamaophthalmol.2021.5052
This cohort study describes the risk of developing diabetes-associated ocular complications among children diagnosed with type 1 or type 2 diabetes during a 50-year period.
Christopher M. Hearon Jr, PhD; Katrin A. Dias, PhD; Gautam Babu, MD; et al.
free access
has active quiz
JAMA Ophthalmol. 2022;140(1):59-65. doi:10.1001/jamaophthalmol.2021.5200
This randomized crossover trial tests the hemodynamic stability and efficacy of a specialized sleeping sack capable of delivering nightly lower body negative pressure.
Twinkle Choksi, MD; Anamika Agrawal, DNB; Purva Date, DNB; et al.
free access
has active quiz
JAMA Ophthalmol. 2022;140(1):66-72. doi:10.1001/jamaophthalmol.2021.5201
This case-control study reports outcomes and cumulative mortality rates among patients with COVID-19–associated rhino-orbitocerebral mucormycosis.
-
Invited Commentary
Rhino-Orbital-Cerebral Mucormycosis—Another Deadly Complication of COVID-19 Infection
Andrea A. Tooley, MD; Elizabeth A. Bradley, MD, MHS; John J. Woog, MD
JAMA Ophthalmol